Match4Health 2024

20–21 Sept 2024 | Larissa, Greece

Bernhard Nussbaumer

Shareholder & CBDO

ACMIT Gmbh

Wiener Neustadt, Austria

34 profile visitsRemote

Medtech Venture Building plus Product Development and Contract Manufacturing - From Idea to Medical Product on Fast Track.

My organisation

ACMIT Gmbh

ACMIT Gmbh

Small Enterprise Company

Wiener Neustadt, Austria

ACMIT is an EN ISO 13485 certified research and development center in the field of medical technology and offers: _+_R&D services all along the process chain from idea to clinical use of a medical device +Services for medical technology startups: e.g. Co-financing, fundraising support: Connecting with European and Austrian funding bodies (e.g. AWS, FFG, accent, INiTS) and international investor network, development milestones according to potential investment rounds +Investment in medtech Startups +QM-System Starter Package (EN ISO 13485) +Support Quality Management and Regulatory Affairs +Contract Manufacturing (small series) of medical devices +Usability Engineering and Testing +Application-oriented anatomical models for medical training, surgical planning and medical device development
Read more

About me

Bernhard Nußbaumer holds an MSc in Electrical Engineering as well as advanced degrees in Business Administration and Entrepreneurial Management. He played a key role in founding and successfully developing several companies in the medical technology sector, including Pantec Biosolutions AG and Pantec Engineering AG, and also drove growth at Berliner Glas KGaA. In 2018, he joined ACMIT GmbH, strategically expanding the company, establishing ACMIT Manufacturing GmbH and ACMIT Ventures, which acts as a technical lead investor in innovative medtech start-ups.

Social media

Skills

  • Business Development
  • Sales
  • R&D Services
  • medtech startups
  • medical technology
  • IP Design
  • patents
  • MDR
  • FDA
  • Regulatory
  • venture builder

Interests

  • innovations for patients
  • IP Design
  • startups
  • Investors
  • medtech
  • Regulatory Affairs
  • Private Equity
  • early stage investment

Marketplace (4)